Live Breaking News & Updates on Lucid Diagnostics Daily|Page 3
Stay updated with breaking news from Lucid diagnostics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Free Report) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 126,600 shares, an increase of 16.4% from the January 15th total of 108,800 shares. Currently, 1.8% of the company’s stock are short sold. Based on an average trading volume […] ....
Contrasting Lucid Diagnostics (NASDAQ:LUCD) and Tandem Diabetes Care (NASDAQ:TNDM) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 108,700 shares, a growth of 12.4% from the October 15th total of 96,700 shares. Approximately 1.1% of the company’s shares are short sold. […] ....
Contrasting Drägerwerk AG & Co. KGaA (OTCMKTS:DGWPF) and Lucid Diagnostics (NASDAQ:LUCD) modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald restated their overweight rating on shares of Lucid Diagnostics (NASDAQ:LUCD – Free Report) in a report released on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $4.00 price target on the stock. Cantor Fitzgerald also issued estimates for Lucid Diagnostics’ FY2023 earnings at ($1.14) EPS and FY2024 earnings at ($0.82) EPS. Separately, […] ....